This document provides an overview of Antimicrobial Awareness Week 2020, including its dates, aims, and topics related to antimicrobial resistance and stewardship in Australia. Key points covered include the link between antibiotic use and resistance, surveillance of antimicrobial use and resistance through the AURA system, evaluating appropriateness of antibiotic prescribing, and the importance of addressing antimicrobial resistance through best practices.
Antibiotic Guardian London Workshop 20164 All of Us
Antibiotic resistance is one of the biggest threats facing us today.
Why it is relevant to you: without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.
What we want you to do: To slow resistance we need to cut the unnecessary use of antibiotics. We invite the public, students and educators, farmers, the veterinary and medical communities and professional organisations, to become Antibiotic Guardians.
Call to action: Choose one simple pledge about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
Antibiotic resistance is one of the biggest threats facing us today.
Why it is relevant to you: without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.
What we want you to do: To slow resistance we need to cut the unnecessary use of antibiotics. We invite the public, students and educators, farmers, the veterinary and medical communities and professional organisations, to become Antibiotic Guardians.
Call to action: Choose one simple pledge about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Antibiotic Guardian London Workshop 20164 All of Us
Antibiotic resistance is one of the biggest threats facing us today.
Why it is relevant to you: without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.
What we want you to do: To slow resistance we need to cut the unnecessary use of antibiotics. We invite the public, students and educators, farmers, the veterinary and medical communities and professional organisations, to become Antibiotic Guardians.
Call to action: Choose one simple pledge about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
Antibiotic resistance is one of the biggest threats facing us today.
Why it is relevant to you: without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.
What we want you to do: To slow resistance we need to cut the unnecessary use of antibiotics. We invite the public, students and educators, farmers, the veterinary and medical communities and professional organisations, to become Antibiotic Guardians.
Call to action: Choose one simple pledge about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
ALKAMAGIC PLAN 1350.pdf plan based of door to door delivery of alkaline water...rowala30
Alka magic plan 1350 -we deliver alkaline water at your door step and you can make handsome money by referral programme
we also help and provide systematic guideline to setup 1000 lph alkaline water plant
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Antibiotics sterwship.pptx
1. Antimicrobial Awareness Week 2020
Insert your organisation’s name here
Insert presenter’s name here
#worldantimicrobialawarenessweek
2. Overview
•Antibiotics are vital life-saving medicines
•Antimicrobial resistance is both a global and local problem
•The link between antibiotic use and resistance
•Addressing antimicrobial resistance in Australia
•Antimicrobial stewardship (AMS)
•Antimicrobial Awareness Week
3. 18 – 24 November
Fixed dates regardless of the first day of the week
Aims to encourage best practice in relation to antibiotic
use, among the general public, health workers and policy
makers to prevent and contain the spread of antimicrobial
resistance.
Antimicrobial Awareness Week in
Australia
4.
5. • Narrow spectrum antibiotics work against a limited group
of bacteria
⎻ Lower resistance potential
• Broad spectrum antibiotics work against a larger group of
bacteria
• Overuse of unnecessarily broad spectrum antibiotics can
drive antimicrobial resistance
Broad vs Narrow Spectrum Antibiotics
Bacteria A Bacteria B Bacteria C Bacteria D Bacteria E Bacteria F Bacteria G
Antibiotic 1
Antibiotic 2
Antibiotic 3
Antibiotic 4
Antibiotic 5
Antibiotic 6
Antibiotic 7
Antibiotic 8
Antibiotic 9
Antibiotic 10
It is preferable to
narrow spectrum
antibiotics wherever
possible
6. The primary purpose of the PAL is to promote improved
prescribing by reducing the total quantity of antibacterial
use. The PAL can be used to describe reductions in a way
that identifies preferred or quality use in terms of AMR and
AMS
Priority Antibacterial List for
Antimicrobial Resistance
Containment
8. • Antimicrobial resistance (AMR) occurs when bacteria,
parasites, viruses or fungi change to protect themselves from
the effects of antimicrobial drugs designed to destroy them.
• This means previously effective antimicrobial drugs (e.g.
antibiotics) used to treat or prevent infections may no longer
work.
• The World Health Organization (WHO) has identified AMR as
‘one of the biggest threats to global health’.
• The Australia’s National Antimicrobial Resistance Strategy -
2020 and Beyond was released and is Australia’s national AMR
strategy.
What is antimicrobial resistance
(AMR)?
9. • Antibiotics treat infections caused by bacteria
• Modern medicine, especially surgery and cancer treatments, depends on effective
antibiotics to minimise the risk of infection
− Currently, antibiotics reduce post-operative infection rates to below 2%
− Without effective antibiotics, this could increase to around 40% to 50%. Up to 30% of
these patients could die from resistant bacterial infections
− The risk of mortality without access to effective antibiotics may make some treatments
and surgical procedures too risky to continue
• Antimicrobial resistance results in substantial financial cost for patients and
healthcare systems.
Why are antibiotics and
antimicrobial resistance important?
11. • In general, the impact of medications are limited to the
patient taking them
• Use of antibiotics has an impact not just for the patient
using them but the global community as well
Antibiotics are a unique medicine
12. • Antimicrobial resistance is a natural phenomenon
• Overuse, misuse and inappropriate use of antibiotics may
accelerate this
• The delivery of more complex health care which may
require longer use of antibiotics
• Prolonged hospitalisation
• The potential impact of surgical procedures undertaken
overseas
• Resistant pathogens can now spread easily
− during hospitalisation if infection prevention is poor
− potential for cross-border transmission through increased travel.
How has antimicrobial resistance
developed?
13.
14. Where do we use
antibiotics? USA
UK
• Humans
⎻ Community
⎻ Hospital
• Animals
⎻ Pets
⎻ Livestock
• Agriculture
⎻ Crops
⎻ Aquaculture
21. • Trends in sales of recently launched antibiotics
discourage pharmaceutical companies to invest in their
research and development
Decline in antibiotic production
22. Robust monitoring and evaluation are needed in
order to measure progress towards the delivery
of the global action plan on antimicrobial
resistance (GAP) objectives, and help identify
key achievements and persisting gaps across
human, animal, plant, food, and environment
sectors in efforts to tackle antimicrobial
resistance
Antimicrobial Resistance – Global
Response
23. In March 2020, the Australian Government released the second
antimicrobial resistance strategy Australia’s National Antimicrobial
Resistance Strategy - 2020 and Beyond to guide the response to the
threat of antimicrobial misuse and resistance.
Objectives:
Australia’s response to antimicrobial
resistance
24. The AURA Surveillance System:
⎻ Coordinates the integration of data
from a range of sources on
antimicrobial use and
antimicrobial resistance
⎻ Contributes significantly to the
development and implementation
of health strategies to respond to,
monitor and prevent antimicrobial
resistance in Australia
Surveillance of Antimicrobial Use
and Resistance in Australia (AURA)
25. • In Australia, antimicrobial resistance also affects aged care homes and
the community. High levels of antibiotic use in the community (which
includes primary and aged care) is a growing concern
• Australia is better placed than many countries to respond to
antimicrobial resistance through having:
- The Antimicrobial Use and Resistance in Australia (AURA) Surveillance
System
- The National Alert System for Critical Antimicrobial Resistances – CARAlert
(as part of AURA)
- The Australian Government’s National Antimicrobial Resistance Strategy
2015-2019
- Initiatives developed and implemented by states and territories, and the
private sector
Australia’s response to antimicrobial
resistance
26. Surveillance of Antimicrobial Use and
Resistance in Australia (AURA)
National
Notifiable
Diseases
Surveillance
System
National
Neisseria
Network
OrgTRx
The AURA National Coordination Unit is responsible for the AURA
Surveillance System. Funding for AURA is provided by the Australian
Government, and state and territory health departments. Multiple partners
contribute data.
27. • Australia has very high usage of antibiotics in the community
⎻ 41.5% of individual Australians received an antibiotic in 2017
⎻ Australia remains in the top 25% of countries with the highest
community usage compared with European countries and Canada
• For the first time since the late 1990s, the rate of antibiotic dispensing
under the PBS/RPBS has declined
• High levels of inappropriate prescribing were found in
⎻ Respiratory tract infections including COPD
⎻ Amoxicillin–clavulanic acid and cefalexin use
AURA 2019 Key Findings –
Antibiotic use in the Community
30. • Treatment failures
• Recurring infections
• Longer hospital stays
• Longer recovery
times
• A higher risk of
mortality or long
term implications
• Significant financial
cost of treatment
Patient impact of antimicrobial
resistant infections
Watch Glen’s Story here
Preventing infections is everybody's business
31. • Which infections are we seeing? [Insert surveillance data,
i.e. what is the most common cause of bacteraemia in your
facility]
• What are our susceptibility and resistance patterns?
⎻ [Insert hospital data]
⎻ [Numbers of cases]
⎻ [Examples of cases]
• Are there local antimicrobial resistance issues?
• What are local rates of MRSA, C diff?
• Do you have access to a local antibiogram?
Antimicrobial resistance locally –
What is happening in our health
service?
32. • This is a placeholder for a local example of a patient who
experienced a resistant bacterial infection at your
healthcare facility
• Insert a case study (optional)
• You may want to detail the:
− diagnosis and the method of diagnosis
− bacterium that was resistant to the preferred antibiotic
− medications used to treat the bacterial infection
− time, resources and people involved to treat the infection
− impact on the patient, the patient’s life and patient’s family
− immediate, medium or long-term health implications (if any).
Patient story
33. Monitoring of Critical Antimicrobial
Resistance (CARAlert)
Link to latest CARAlert Report
Species Critical resistance
Acinetobacter baumannii complex Carbapenemase-producing
Candida auris –
Enterobacterales Carbapenemase-producing, and/or
ribosomal methyltransferase-producing
Enterobacterales Transmissible colistin resistance
Enterococcus species Linezolid resistant
Mycobacterium tuberculosis Multidrug-resistant (resistant to at least
rifampicin and isoniazid)
Neisseria gonorrhoeae Ceftriaxone non-susceptible or azithromycin
non-susceptible
Salmonella species Ceftriaxone non-susceptible
Shigella species Multidrug-resistant
Staphylococcus aureus Vancomycin, linezolid or daptomycin non-
susceptible
Streptococcus pyogenes Penicillin reduced susceptibility
Pseudomonas aeruginosa Carbapenemase-producing
34. • Resistance mechanisms to ‘last-line’ antibiotics
• 2,979 results – January 2017 to December 2018
• Azithromycin- or ceftriaxone-nonsusceptible Neisseria gonorrhoeae
was the most frequently reported in 2017 (48% of isolates)
• Carbapenemase producing Enterobacterales (CPE) were the most
frequently reported in 2019 (49% of isolates)
• Over three-quarters of all CARs were from clinical specimens
including urine, wound, blood
Critical Antimicrobial Resistances
(CAR)
35. The National Antimicrobial Utilisation Surveillance Program (NAUSP) is a partner in
AURA and collects data on antimicrobial use.
Factors that are likely to have contributed to reduced use include:
• Increased capacity of local, state and territory, and national AMS programs
• Changes in clinical practice
• More effective adoption of recommendations in Therapeutic Guidelines: Antibiotic.
Aggregate Hospital Antibiotic Use
2017 (NAUSP)
Figure 3.1: Annual total-hospital aggregate antibiotic usage rate (DDD/1,000 OBD) in NAUSP
contributor hospitals, 2007–2017
36. • Insert local antibiotic use data (if available)
• Include information about your contributions to National
Antimicrobial Usage Surveillance Program (NAUSP)
• Insert NAUSP data.
Local Antibiotic Use
37. Whilst antimicrobial utilisation is a good measure for the success of
antimicrobial prescribing interventions it does not assess why the
antimicrobial was used.
Utilisation: how much we use?
Appropriateness: was it a good choice?
Utilisation vs Appropriateness
38. • National Antimicrobial Prescribing Survey (NAPS) - In 2017, 22.4%
of all prescriptions from all participants were deemed
“inappropriate” (n= 24,987 prescriptions)
Appropriateness of prescribing in
Australia
39. • Does your healthcare facility audit appropriateness of prescribing?
• What tools are used (e.g.. National Antimicrobial Prescribing Survey
[NAPS], jurisdictional audit tools)
• If participating in NAPS, insert your healthcare facilities results here:
• Consider
− results compared to national results
− Time series data
− how the your facility’s NAPS results have contributed to your AMS
program.
Appropriateness of prescribing at
our hospital
40. May increase risk of
adverse effects, including:
⎻ AMR (current and
future patients)
⎻ Antimicrobial allergy
⎻ Treatment failure
⎻ Toxicity (e.g.
ototoxicity)
⎻ Clostridioides difficile
(formely called Clostridium
difficile)
⎻ Increased health care
costs (i.e. length of
stay)
Why is inappropriate use important?
Reason Yes (%) No (%)
Not
specified
(%)
Spectrum too
broad
21.9% 46.3% 31.8%
Incorrect dose or
frequency
20.1% 50.9% 29.0%
Antimicrobial not
required
17.5% 49.8% 32.7%
Incorrect duration 16.5% 51.0% 32.5%
Spectrum too
narrow
6.6% 58.8% 34.6%
Incorrect route 5.2% 60.6% 34.3%
n = 5,864
Reasons for a reported prescription being
assessed as inappropriate, Hospital NAPS
contributors, 2017
41.
42. • In 2017, a large proportion of the Australian population
had at least one antimicrobial dispensed under the PBS
(41.5%, n = 10,215,109)
Antibiotics in primary care –
Pharmaceutical Benefit Scheme
(PBS)
Figure 3.24: Quantity of antibiotics dispensed under the PBS/RPBS
(DDD/1,000 inhabitants/day), 2013–2017
43. • The Antimicrobial Medicines Dispensing from 2013–14 to
2017–18 report out today also has some encouraging
findings, with a downward trend in national antimicrobial
dispensing rates, which fell 13.3% over five years.
• Australia’s antimicrobial prescription rate remains high
by international standards, and is double that of
comparable OECD countries such as The Netherlands and
Sweden
Antibiotics in Primary Care
44. • In 2017, only 33.4% of antibiotics prescribed had the
reason for the prescription recorded
• An indication for antibiotic use could not be identified for
30% of prescriptions
• Patients still received antibiotic prescriptions for
influenza/upper respiratory tract infections
⎻ But antimicrobials are not generally recommended for these
conditions
Antibiotics in primary care –
NPS MedicineWise Medicine Insight
45. • Variation raises concerns about equity and safety and
appropriateness of care
• There is marked variation in use of antibiotics
− between states
− between hospitals
different sizes
within the same size
• The reasons for this are not well understood
• Also marked variation in community dispensing of antibiotics in
2016-17
− The magnitude of variation was 4.5 times
− A reduction in the rate of antimicrobial prescriptions nationally by 9%
compared to 2013-14
Understanding Variation
46. Antimicrobial Stewardship isn’t about “not using antimicrobials”
but rather “identify that small group of patients who really need
antibiotic treatment and then explain, reassure and educate the
large group of patients who don’t”
• Stewardship means to protect something
• AMS is a systematic approach to optimising the use of antimicrobials
• Goals of AMS are to:
‒ improve patient outcomes / patient safety
‒ reduce antimicrobial resistance
‒ reduce costs.
• AMS works hand-in-hand with infection prevention and control, and
environmental cleaning strategies
Antimicrobial Stewardship (AMS)
47. Safety – bring up to the minimum
acceptable and sustainable
standard
Quality – aspiring to the best
possible quality and effectiveness
of care
Equity – ensuring every patient
regardless of their cultural or
linguistic background has the same
experience of care
Has the right patient received the
right antibiotic, at the right time, at
the right dose, via the right route
for the right duration?
Is there a systematic approach to
ensure each patient using
antimicrobials is managed with the
principles of AMS?
Does your organisation keep up to
date with the latest evidence and
strive to innovate and implement
that standard of care?
Antimicrobial Stewardship (AMS) –
Safety, Quality and Equity dimensions
50. • Clear organisational structure and governance
• Executive and clinical leadership
• AMS advisory committee
• Multidisciplinary clinical AMS team
• Expert advice from
− infectious diseases experts
− microbiologists
− pharmacists
• Education and training
− prescribers, pharmacists, nurses
− consumers
• Information technology resources.
Enablers for effective for AMS
Programs - Hospitals
51. Essential strategies for AMS
Programs - Hospitals
Pre-prescription Post-prescription
Formulary management Direct patient input e.g. AMS Round
Restriction System Audit and Feedback
Guidelines Monitor appropriateness – National
Antimicrobial Prescribing Survey (NAPS)
Education Monitor utilisation – National Antimicrobial
Utilisation Surveillance Program (NAUSP)
Antibiograms (susceptibility of
microogranisms to antimicrobials)
Education
Selective reporting of susceptibility
testing
Electronic solutions - eMeds – automatic stops
Confirming patient’s allergy status IV to Oral switch
52. Insert information on
your AMS service:
⎻ Structure, governance –
who is responsible?
⎻ Who leads AMS
activities?
⎻ Who is on your local
AMS team?
⎻ What AMS activities are
undertaken?
⎻ What AMS activities are
you / your department
involved in?
Antimicrobial Stewardship in our
healthcare facility
AMS
Team
Microbiologist
Infectious
Diseases
Specialist
Antimicrobial
Stewardship
Pharmacist
Infection
Control Nurses
AMS
Pharmacy
Technician
53. • In the community
⎻ General Practice
Not prescribing antibiotics for colds and
flu
Delayed prescribing
Shared decision making
Public declarations in the practice about
conserving antibiotics
⎻ Pharmacies
Offering symptomatic support for cold
and flu
Antimicrobial Stewardship – not just
for hospitals
54. • In the home
⎻ Not taking antibiotics that haven’t been prescribed for you
⎻ Discarding old antibiotic medicines appropriately
• In industry
⎻ Investing in research and development for antimicrobials
55. • COVID-19 pandemic has presented many additional
challenges (including antimicrobial shortages) for
managing patients with infections
• It is even more important to prevent infections and
reduce inappropriate antibiotic use
• Key message:
⎻ Explain to patient that antibiotics do not prevent or treat COVID-
19 but can cause adverse effects, allergic reactions, drug
interactions and increase risk of future resistant infections
AMS during COVID-19
56.
57.
58. • New Chapters!
⎻ General Practice – Published!
⎻ In the Care of Children – Published!
⎻ Aboriginal and Torres Strait Islander Populations – on the way
AMS in Australian Health Care Book
62. • Always use the most current
version
⎻ Currently version 16, 2019
⎻ Now only in online format
• Check hospital intranet
• A ‘go to’ reference, especially
where there are limited local
guidelines
• Learn more
⎻ www.tg.org.au
⎻ click ‘Products’, then ‘Antibiotic’
Therapeutic Guidelines: Antibiotic
63. • Use this slide to highlight any AMS initiatives your
organisation has completed recently
• This may be
⎻ A new guideline
⎻ A new audit
⎻ A new service or multidisciplinary team success
64. Insert information on AAW in your
health service:
• Join the conversation on social media:
⎻ Hashtags
#worldantimicrobialawarenessweek
#WAAW
#AntibioticResistance
#AMR
⎻ @ACSQHC
• Local activities and contact people
• Include information about local
activities
Local Antibiotic Awareness Week
Activities
65. Ideas!
• Get Creative
• Pick a target area
• Examples
• IV to Oral Switch
• Penicillin Allergy
• Surgical Prophylaxis
66. Antimicrobial resistance:
⎻ occurs when an organism evolves and develops resistance to an
antimicrobial that should inhibit or destroy it
⎻ is reducing the effectiveness of antimicrobials to treat infections
⎻ is happening now
• Few new antimicrobials are being developed
• The misuse, overuse, and inappropriate use of
antimicrobials contributes to antimicrobial resistance
• Antimicrobial stewardship works hand in hand with
prevention and control strategies to help address
antimicrobial resistance.
Key messages
68. References
Slide
Number
Website
4 https://www.reactgroup.org/toolbox/understand/antibiotics/
6 https://www.safetyandquality.gov.au/publications-and-resources/resource-library/priority-antibacterial-list-
antimicrobial-resistance-containment
10 Image - https://www.researchgate.net/figure/Total-deaths-projected-by-2050-attributable-to-antimicrobial-resistance-
AMR-every-year_fig2_340990507
11 Image - http://blog.nus.edu.sg/singaporesling/2016/11/16/the-resistible-rise-of-antibiotic-resistance/
13 Image courtesy of CDC / Melissa Brower Centers for Disease Control and Prevention Public Health Image Library
http://phil.cdc.gov/phil/home.asp
14 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/843129/English_Sur
veillance_Programme_for_Antimicrobial_Utilisation_and_Resistance_2019.pdf
https://www.nejm.org/doi/full/10.1056/nejmp1311479
15 https://www.businessinsider.com.au/alexander-fleming-predicted-post-antibiotic-era-70-years-ago-2015-7
69. References
Slide
Number
Website
16 https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/carbapenem-resistant-
enterobacteriaceae-risk-assessment-april-2016.pdf
17 Source: The Antimicrobial Resistance Standing Committee (2013)
National Surveillance and Reporting of Antimicrobial Resistance and Antibiotic Usage for Human Health in
Australia.
18 AURA 2019 Report - https://www.safetyandquality.gov.au/aura-2019
19 AURA 2019 Report - https://www.safetyandquality.gov.au/aura-2019
20 Butler M, Blaskovich M, Cooper M. Antibiotics in the clinical pipeline in 2013. J. Antibiot 2013;66: 571-591
21 Lee Ventola C. The Antibiotic Resistance Crisis Part 1: Causes and Threats. P T 2015 Apr; 40(4): 277–283
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/
Fernandes V, Martens E. Antibiotics in late clinical development. Biochemical Pharmacology 2017 June 1; 133: 152-163
https://www.sciencedirect.com/science/article/pii/S0006295216303082
22 https://apps.who.int/iris/handle/10665/325006